NPAT is found mutated in several cancer types including lung cancer28 and malignant melanoma29, and germline NPATmut was recently identified as a candidate risk factor for Hodgkin lymphoma30, thereby suggesting also a possible implication in AML pathogenesis. The gene discussed is NPAT; the disease is acute myeloid leukemia.